Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands.
Vox Sang. 2011 Apr;100(3):312-6. doi: 10.1111/j.1423-0410.2010.01408.x. Epub 2010 Sep 17.
To evaluate neonatal outcome in Kell haemolytic disease compared to Rh D haemolytic disease.
Retrospective study of all (near)-term neonates with Kell (n=34) and Rh D haemolytic disease (n=157) admitted to our centre between January 2000 and December 2008. We recorded the need for exchange transfusion and top-up transfusions up to 3 months of age.
Neonates in the Kell group required less days of phototherapy than neonates in the Rh D group [2.4 vs. 4.1 days, respectively (P<0.01)]. The percentage of neonates requiring an exchange transfusion was lower in the Kell group than in the Rh D group [6% (2/34) and 62% (98/157), respectively (P<0.01)]. The percentage of neonates in the Kell group and Rh D group requiring a top-up transfusion was 62% (21/34) and 72% (113/157), respectively (P=0.20). The median number of top-up transfusions per neonate in the Kell group and Rh D group was 1 [interquartile range (IQR) 0-2] and 2(IQR 0-2), respectively (P=0.07).
Neonates with Kell haemolytic disease require less phototherapy and less exchange transfusions compared to neonates with Rh D haemolytic disease, but an equal number of top-up transfusions.
评估 Kell 溶血病新生儿结局与 RhD 溶血病新生儿结局。
对 2000 年 1 月至 2008 年 12 月在我院住院的所有(近)足月 Kell(n=34)和 RhD 溶血病(n=157)新生儿进行回顾性研究。我们记录了新生儿在 3 个月龄内需要换血治疗和追加输血的情况。
Kell 组新生儿接受光照治疗的天数少于 RhD 组[分别为 2.4 天和 4.1 天(P<0.01)]。Kell 组需要换血治疗的新生儿比例低于 RhD 组[分别为 6%(2/34)和 62%(98/157)(P<0.01)]。Kell 组和 RhD 组需要追加输血的新生儿比例分别为 62%(21/34)和 72%(113/157)(P=0.20)。Kell 组和 RhD 组每个新生儿接受的追加输血中位数分别为 1 [四分位间距(IQR)0-2]和 2(IQR 0-2)(P=0.07)。
与 RhD 溶血病新生儿相比,Kell 溶血病新生儿需要较少的光照治疗和换血治疗,但需要接受同等数量的追加输血。